Dr. Ari A Sugiharto
Polymyositis and dermatomyositis are both systemic autoimmune diseases that are commonly associated with cutaneous disease, interstitial lung disease (ILD), or interstitial pneumonia (IP) (1). The reported prevalence of ILD in patients with PM/DM ranges from 20% to 78%. Two corticosteroids are generally used as first-line therapy for the treatment
<p>Tacrolimus in Patients with Polymyositis or Dermatomyositis with Interstitial Pneumonia: Insights from Post-surveillance Analysis</p>

Tacrolimus in Patients with Polymyositis or Dermatomyositis with Interstitial Pneumonia: Insights from Post-surveillance Analysis

782 Reached1 Comments

Similar Content

Acute Renal Failure in Child Due to High Dose of Indomethacin
Acute Renal Failure in Child Due to High Dose of Indomethacin
685 Reached6 Comments
Fremanezumab for Prevention and Treatment of Migraine
Fremanezumab for Prevention and Treatment of Migraine
390 Reached13 Comments11 Likes
Case of Pulmonary Embolism with Syncope
Case of Pulmonary Embolism with Syncope
544 Reached4 Likes
Plastic Bronchitis in an Infant
Plastic Bronchitis in an Infant
449 Reached
Study to Test Tofacitinib Efficacy for Psoriatic Arthritis
Study to Test Tofacitinib Efficacy for Psoriatic Arthritis
446 Reached2 Comments4 Likes